JP Patent

JP6482475B2 — アンチセンスオリゴヌクレオチド及び糖誘導体を含む二本鎖オリゴヌクレオチド

Assigned to Rena Therapeutics Inc · Expires 2019-03-13 · 7y expired

What this patent protects

Patent listed against eplontersen-sodium.

Drugs covered by this patent

eplontersen-sodium (EPLONTERSEN SODIUM)

Patent Metadata

Patent number: JP6482475B2
Jurisdiction: JP
Classification: —
Expires: 2019-03-13
Drug substance claim: No
Drug product claim: No
Assignee: Rena Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.